These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3303074)

  • 1. Elimination of residual tumor cells from autologous bone marrow grafts by dye-mediated photolysis: preclinical data.
    Sieber F
    Photochem Photobiol; 1987 Jul; 46(1):71-6. PubMed ID: 3303074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts.
    Yamazaki T; Sato Y; Sieber F
    Exp Hematol; 1997 Jul; 25(7):629-37. PubMed ID: 9216739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor effect of Merocyanine 540-mediated photochemotherapy combined with Edelfosine: potential implications for the ex vivo purging of hematopoietic stem cell grafts from breast cancer patients.
    Anderson GS; Miyagi K; Sampson RW; Sieber F
    J Photochem Photobiol B; 2002 Nov; 68(2-3):101-8. PubMed ID: 12468204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of merocyanine 540-mediated photodynamic therapy by salicylate and related drugs.
    Traul DL; Anderson GS; Bilitz JM; Krieg M; Sieber F
    Photochem Photobiol; 1995 Oct; 62(4):790-9. PubMed ID: 7480156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential killing of murine B-cell leukemia (BCL1) by photosensitization with merocyanine 540: implications for autologous bone marrow transplantation.
    Mumcuoglu M; Weiss L; Spivak J; Slavin S
    Bone Marrow Transplant; 1989 Mar; 4(2):143-6. PubMed ID: 2650782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alkyl-lysophospholipid, ET-18-OCH3 synergistically enhances the Merocyanine 540-mediated photoinactivation of leukemia cells: implications for the extracorporeal purging of autologous hematopoietic stem cells.
    Yamazaki T; Sieber F
    Bone Marrow Transplant; 1997 Jan; 19(2):113-9. PubMed ID: 9116607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dye-mediated photosensitization of murine neuroblastoma cells.
    Sieber F; Sieber-Blum M
    Cancer Res; 1986 Apr; 46(4 Pt 2):2072-6. PubMed ID: 3512078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dye-mediated photolysis of human neuroblastoma cells: implications for autologous bone marrow transplantation.
    Sieber F; Rao S; Rowley SD; Sieber-Blum M
    Blood; 1986 Jul; 68(1):32-6. PubMed ID: 3521764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of merocyanine 540-mediated photodynamic therapy on cellular immune functions: A role in the prophylaxis of graft-versus-host disease?
    Traul DL; Sieber F
    J Photochem Photobiol B; 2015 Dec; 153():153-63. PubMed ID: 26410039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hypothermia on the merocyanine 540-mediated purging of hematopoietic cells.
    Yamazaki T; Sieber F
    J Hematother; 1997 Feb; 6(1):31-9. PubMed ID: 9112216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of leukemic cells by laser photodynamic therapy.
    Gulliya KS; Fay JW; Dowben RM; Berkholder S; Matthews JL
    Cancer Chemother Pharmacol; 1988; 22(3):211-4. PubMed ID: 3165726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of merocyanine 540-mediated phototherapy by salicylate.
    Anderson MS; Kalyanaraman B; Feix JB
    Cancer Res; 1993 Feb; 53(4):806-9. PubMed ID: 8381329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of the antitumor effect of Merocyanine 540-mediated photodynamic therapy by amifostine and amphotericin B.
    Tsujino I; Miyagi K; Sampson RW; Sieber F
    Photochem Photobiol; 2006; 82(2):458-65. PubMed ID: 16613499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selenoperoxidase-mediated cytoprotection against merocyanine 540-sensitized photoperoxidation and photokilling of leukemia cells.
    Lin F; Geiger PG; Girotti AW
    Cancer Res; 1992 Oct; 52(19):5282-90. PubMed ID: 1394132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential inactivation of paediatric solid tumour cells by sequential exposure to Merocyanine 540-mediated photodynamic therapy and Edelfosine: implications for the ex vivo purging of autologous haematopoietic stem cell grafts.
    Anderson GS; Tsujino I; Miyagi K; Sampson R; Sieber F
    J Photochem Photobiol B; 2003 Feb; 69(2):87-95. PubMed ID: 12633981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodamaging effects of merocyanine 540 on neutrophils and HL-60 cells.
    Smith OM; Traul DL; Sieber F
    Exp Hematol; 1992 Dec; 20(11):1278-84. PubMed ID: 1337324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Merocyanine 540-sensitized photoinactivation of leukemia cells: effects of dose fractionation.
    Qiu K; Sieber F
    Photochem Photobiol; 1992 Oct; 56(4):489-93. PubMed ID: 1454878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of clonogenic tumor cells from HL-60, Daudi, and U-937 cell lines by laser photoradiation therapy: implications for autologous bone marrow purging.
    Gulliya KS; Pervaiz S
    Blood; 1989 Mar; 73(4):1059-65. PubMed ID: 2920207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer and laser photoradiation therapy: an in vitro model for autologous bone marrow purging.
    Gulliya KS; Batagllino M; Matthews JL
    Prog Clin Biol Res; 1990; 333():103-7. PubMed ID: 2308975
    [No Abstract]   [Full Text] [Related]  

  • 20. [Merocyanine 540-mediated photodynamic therapy inhibits P-glycoprotein (P-gp) activity in adriamycin-resistant K562 cells].
    Sato Y; Yamazaki T; Yasukawa K; Kaneita Y; Mochimaru J; Hanai M; Irie T; Kura Y; Sawada U; Horie T
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2195-200. PubMed ID: 10635304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.